Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 20:385–397. https://doi.org/10.1016/s1474-4422(21)00030-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. https://doi.org/10.1136/jnnp.55.3.181

Article  CAS  PubMed  PubMed Central  Google Scholar 

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601. https://doi.org/10.1002/mds.26424

Article  PubMed  Google Scholar 

Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease. Neurology 86:566–576. https://doi.org/10.1212/WNL.0000000000002350

Article  PubMed  Google Scholar 

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D (2018) Validation of the MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 33:1601–1608. https://doi.org/10.1002/mds.27362

Article  CAS  PubMed  Google Scholar 

Marshall VL, Reininger CB, Marquardt M, Patterson J, Hadley DM, Oertel WH, Benamer HT, Kemp P, Burn D, Tolosa E, Kulisevsky J, Cunha L, Costa D, Booij J, Tatsch K, Chaudhuri KR, Ulm G, Pogarell O, Hoffken H, Gerstner A, Grosset DG (2009) Parkinson’s disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord 24:500–508. https://doi.org/10.1002/mds.22108

Article  PubMed  Google Scholar 

Magalhães P, Lashuel HA (2022) Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies. NPJ Parkinson’s Dis 8:93. https://doi.org/10.1038/s41531-022-00357-0

Article  CAS  Google Scholar 

Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R (2019) Value of in vivo α-synuclein deposits in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 34:1452–1463. https://doi.org/10.1002/mds.27794

Article  CAS  PubMed  Google Scholar 

Luan M, Sun Y, Chen J, Jiang Y, Li F, Wei L, Sun W, Ma J, Song L, Liu J, Liu B, Pei Y, Wang Z, Zhu L, Deng J (2022) Diagnostic value of salivary real-time quaking-induced conversion in Parkinson’s disease and multiple system atrophy. Mov Disord 37:1059–1063. https://doi.org/10.1002/mds.28976

Article  CAS  PubMed  Google Scholar 

Vivacqua G, Mason M, De Bartolo MI, Węgrzynowicz M, Calò L, Belvisi D, Suppa A, Fabbrini G, Berardelli A, Spillantini M (2023) Salivary α-Synuclein RT-QuIC correlates with disease severity in de novo Parkinson’s disease. Mov Disord 38:153–155. https://doi.org/10.1002/mds.29246

Article  CAS  PubMed  Google Scholar 

Zheng Y, Li S, Yang C, Yu Z, Jiang Y, Feng T (2023) Comparison of biospecimens for alpha-synuclein seed amplification assays in Parkinson’s disease: a systematic review and network meta-analysis. Eur J Neurol 30:3949–3967. https://doi.org/10.1111/ene.16041

Article  PubMed  Google Scholar 

Li J, Duan S, Yang J, Zheng H, Yuan Y, Tang M, Wang Y, Liu Y, Xia Z, Luo H, Xu Y (2024) Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson’s disease in the Chinese population. Eur J Med Res 29:114. https://doi.org/10.1186/s40001-024-01705-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gibbons C, Wang N, Rajan S, Kern D, Palma JA, Kaufmann H, Freeman R (2023) Cutaneous α-synuclein signatures in patients with multiple system atrophy and Parkinson disease. Neurology 100:e1529–e1539. https://doi.org/10.1212/wnl.0000000000206772

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melli G, Vacchi E, Biemmi V, Galati S, Staedler C, Ambrosini R, Kaelin-Lang A (2018) Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease. Ann Clin Transl Neurol 5:1394–1407. https://doi.org/10.1002/acn3.669

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J, Agarwal P, Aldridge GM, Barboi A, Evidente VGH, Galasko D, Geschwind MD, Gonzalez-Duarte A, Gil R, Gudesblatt M, Isaacson SH, Kaufmann H, Khemani P, Kumar R, Lamotte G, Liu AJ, McFarland NR, Miglis M, Reynolds A, Sahagian GA, Saint-Hillaire MH, Schwartzbard JB, Singer W, Soileau MJ, Vernino S, Yerstein O, Freeman R (2024) Skin biopsy detection of phosphorylated α-synuclein in patients with synucleinopathies. JAMA 331:1298–1306. https://doi.org/10.1001/jama.2024.0792

Article  CAS  PubMed  PubMed Central  Google Scholar 

Michell AW, Luheshi LM, Barker RA (2005) Skin and platelet α-synuclein as peripheral biomarkers of Parkinson’s disease. Neurosci Lett 381:294–298. https://doi.org/10.1016/j.neulet.2005.02.030

Article  CAS  PubMed  Google Scholar 

Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810–813. https://doi.org/10.1038/35081095

Article  CAS  PubMed  Google Scholar 

Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C (2017) Development of a biochemical diagnosis of Parkinson disease by detection of α-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74:163–172. https://doi.org/10.1001/jamaneurol.2016.4547

Article  PubMed  Google Scholar 

Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MT, Parkkinen L, Green AJ (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812–818. https://doi.org/10.1002/acn3.338

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manne S, Kondru N, Jin HJ, Serrano GE, Anantharam V, Kanthasamy A, Adler CH, Beach TG, Kanthasamy AG (2020) Blinded RT-QuIC analysis of α-synuclein biomarker in skin tissue from Parkinson’s disease patients. Mov Disord 35:2230–2239. https://doi.org/10.1002/mds.28242

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoo D, Bang JI, Ahn C, Nyaga VN, Kim YE, Kang MJ, Ahn TB (2022) Diagnostic value of alpha-synuclein seeding amplification assays in alpha-synucleinopathies: a systematic review and meta-analysis. Parkinsonism Relat Disord 104:99–109. https://doi.org/10.1016/j.parkreldis.2022.10.007

Article  CAS  PubMed  Google Scholar 

De Luca CMG, Elia AE, Portaleone SM, Cazzaniga FA, Rossi M, Bistaffa E, De Cecco E, Narkiewicz J, Salzano G, Carletta O, Romito L, Devigili G, Soliveri P, Tiraboschi P, Legname G, Tagliavini F, Eleopra R, Giaccone G, Moda F (2019) Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy. Transl Neurodegener 8:24. https://doi.org/10.1186/s40035-019-0164-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoo D, Bang JI, Ahn C, Nyaga VN, Kim YE, Kang MJ, Ahn TB (2022) Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: a systematic review and meta-analysis. Parkinsonism Relat Disord 104:99–109. https://doi.org/10.1016/j.parkreldis.2022.10.007

Article  CAS  PubMed  Google Scholar 

Donadio V, Incensi A, Leta V, Giannoccaro MP, Scaglione C, Martinelli P, Capellari S, Avoni P, Baruzzi A, Liguori R (2014) Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology 82:1362–1369. https://doi.org/10.1212/wnl.0000000000000316

Article  CAS  PubMed  Google Scholar 

Schaeffer E, Kluge A, Schulte C, Deuschle C, Bunk J, Welzel J, Maetzler W, Berg D (2024) Association of misfolded α-synuclein derived from neuronal exosomes in blood with Parkinson’s disease diagnosis and duration. J Parkinsons Dis 14:667–679. https://doi.org/10.3233/jpd-230390

Article  CAS  PubMed  PubMed Central